Related Experiment Video

Updated: Oct 21, 2025

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
06:19

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches

Published on: June 16, 2023

3.5K

Antibodies Targeting KV Potassium Channels: A Promising Treatment for Cancer

Ileana Hernandez-Resendiz1, Franziska Hartung1, Luis A Pardo1

  • 1AG Oncophysiology, Max Planck Institute for Experimental Medicine, Göttingen, Germany.

Bioelectricity
|September 2, 2021
PubMed

Insights

Voltage-gated potassium channels (KV) regulate vital cell functions. Targeting these channels shows promise for cancer therapy due to their altered expression in many cancers, correlating with poor prognosis.

Area of Science:

  • Molecular Biology
  • Cell Physiology
  • Oncology

Background:

  • Voltage-gated potassium channels (KV) are crucial transmembrane proteins regulating ion homeostasis, cell proliferation, migration, and muscular contraction.
  • Altered KV channel expression is linked to various pathologies, including heart arrhythmia and cancer, often correlating with malignancy and poor prognosis.

Purpose of the Study:

  • To review strategies for targeting voltage-gated potassium channels (KV) as a potential cancer therapy approach.
  • To discuss the advantages and obstacles associated with targeting KV channels in cancer treatment, leveraging available structural understanding.

Main Methods:

  • Literature review of existing research on voltage-gated potassium channels (KV).
  • Analysis of structural information and functional roles of KV channels in cellular processes and disease.
  • Exploration of therapeutic strategies targeting KV channels in the context of cancer.

Main Results:

  • KV channels play significant roles in cell proliferation, migration, and volume, processes critical in cancer development.
  • Aberrant expression of KV channels is a hallmark of many cancers, associated with increased malignancy and reduced patient survival.
  • Targeting KV channels presents a promising, yet challenging, therapeutic avenue in oncology.

Conclusions:

  • Voltage-gated potassium channels (KV) represent a viable target for novel cancer therapies.
  • Further research into KV channel structure and function can guide the development of effective anti-cancer drugs.
  • Overcoming obstacles in KV channel targeting may unlock new treatment strategies for various malignancies.
Keywords:
antibodiescancerimmunotherapypotassium channels

More Related Videos

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels10:07

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels

Published on: January 27, 2013

15.3K
Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting10:08

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting

Published on: December 9, 2022

2.4K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
303
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
368
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
7.6K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.4K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
570